(Q42412173)

30 October 2017

Lessons from the withdrawal of rofecoxib (English)

1 reference

30 October 2017

4

Peter Jüni

1 reference

30 October 2017

2

Shah Ebrahim

1 reference

30 October 2017

3

Richard M Martin

1 reference

30 October 2017

1

Paul A Dieppe

1 reference

PMC publication ID

523096

30 October 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

30 October 2017

1 reference

30 October 2017

329

1 reference

30 October 2017

7471

1 reference

30 October 2017

867-868

1 reference

Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

A model for the future conduct of pharmacovigilance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Risk of cardiovascular events associated with selective COX-2 inhibitors

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Medical journals and pharmaceutical companies: uneasy bedfellows.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523096

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15485938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.329.7471.867

1 reference

30 October 2017

1 reference

PMC publication ID

523096

30 October 2017

PubMed publication ID

15485938

1 reference

PMC publication ID

523096